Rejuvesol

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 23731-7000
  • Package NDC 23731-7000-5
  • Application number BN950522
  • SPL ID f07bc3c3-29f0-4f71-9696-47a1c2ec5bf2
  • SPL set ID bc06c40f-81a0-45e5-80b6-61f67d445068
  • UNII POD38AIF08
  • UNII 5A614L51CT
  • UNII JAC85A2161
  • UNII GR686LBA74
  • UNII 593YOG76RN

What the source publishes

Labeler
Citra Labs, LLC
Active ingredients
Sodium Pyruvate, Inosine, Adenine, Sodium Phosphate, Dibasic, and Sodium Phosphate, Monobasic, Monohydrate
Form
SOLUTION
Routes
EXTRACORPOREAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:23731-7000_f07bc3c3-29f0-4f71-9696-47a1c2ec5bf2
{
  "name": "Rejuvesol",
  "splId": "f07bc3c3-29f0-4f71-9696-47a1c2ec5bf2",
  "labels": [
    {
      "setId": "bc06c40f-81a0-45e5-80b6-61f67d445068",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc06c40f-81a0-45e5-80b6-61f67d445068",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bc06c40f-81a0-45e5-80b6-61f67d445068"
    }
  ],
  "routes": [
    "EXTRACORPOREAL"
  ],
  "labeler": "Citra Labs, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "12 VIAL, SINGLE-USE in 1 CASE (23731-7000-5)  / 50 mL in 1 VIAL, SINGLE-USE",
      "package_ndc": "23731-7000-5",
      "identifierStatus": "well-formed",
      "marketing_start_date": "19970226"
    }
  ],
  "productId": "23731-7000_f07bc3c3-29f0-4f71-9696-47a1c2ec5bf2",
  "useDomain": "unknown",
  "dosageForm": "SOLUTION",
  "productNdc": "23731-7000",
  "deaSchedule": null,
  "genericName": "Sodium Pyruvate, Inosine, Adenine, Sodium Phosphate, Dibasic, and Sodium Phosphate, Monobasic, Monohydrate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "SODIUM PYRUVATE",
      "strength": ".55 g/50mL"
    },
    {
      "name": "INOSINE",
      "strength": "1.34 g/50mL"
    },
    {
      "name": "ADENINE",
      "strength": ".034 g/50mL"
    },
    {
      "name": "SODIUM PHOSPHATE, DIBASIC",
      "strength": ".73 g/50mL"
    },
    {
      "name": "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE",
      "strength": ".311 g/50mL"
    }
  ],
  "applicationNumber": "BN950522",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "19970226",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "POD38AIF08",
      "5A614L51CT",
      "JAC85A2161",
      "GR686LBA74",
      "593YOG76RN"
    ],
    "spl_set_id": [
      "bc06c40f-81a0-45e5-80b6-61f67d445068"
    ],
    "manufacturer_name": [
      "Citra Labs, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:23731-7000_f07bc3c3-29f0-4f71-9696-47a1c2ec5bf2"